PLX PHARMA INC's ticker is PLXP and the CUSIP is 72942A107. A total of 17 filers reported holding PLX PHARMA INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $5,371 | -20.7% | 41,285 | 0.0% | 0.00% | – |
| Q4 2022 | $6,775 | -74.9% | 41,285 | 0.0% | 0.00% | – |
| Q3 2022 | $27,000 | -73.0% | 41,285 | 0.0% | 0.00% | – |
| Q2 2022 | $100,000 | -47.4% | 41,285 | -12.0% | 0.00% | – |
| Q1 2022 | $190,000 | -51.0% | 46,925 | -3.2% | 0.00% | – |
| Q4 2021 | $388,000 | -53.1% | 48,462 | +13.0% | 0.00% | – |
| Q3 2021 | $827,000 | +34.7% | 42,869 | -3.7% | 0.00% | – |
| Q2 2021 | $614,000 | +89.5% | 44,513 | +23.9% | 0.00% | – |
| Q1 2021 | $324,000 | +489.1% | 35,932 | +257.8% | 0.00% | – |
| Q4 2020 | $55,000 | +120.0% | 10,043 | -8.5% | 0.00% | – |
| Q1 2020 | $25,000 | -47.9% | 10,980 | 0.0% | 0.00% | – |
| Q4 2019 | $48,000 | -15.8% | 10,980 | -0.2% | 0.00% | – |
| Q3 2019 | $57,000 | -28.8% | 11,003 | -0.9% | 0.00% | – |
| Q2 2019 | $80,000 | +35.6% | 11,103 | 0.0% | 0.00% | – |
| Q1 2019 | $59,000 | – | 11,103 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 62,673 | $254,000 | 0.31% |
| Park West Asset Management LLC | 1,075,723 | $4,357,000 | 0.16% |
| Harel Insurance Investments & Financial Services Ltd. | 550,000 | $2,228,000 | 0.11% |
| CVI Holdings, LLC | 13,878 | $56,000 | 0.09% |
| Heritage Way Advisors, LLC | 12,000 | $49,000 | 0.03% |
| Cranbrook Wealth Management, LLC | 7,500 | $30,000 | 0.01% |
| BROWN ADVISORY INC | 75,000 | $304,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 11,000 | $45,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 86,209 | $349,000 | 0.00% |